ConductScience.org, home

Paper34829969

Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges.

Kandimalla R and 7 others. Biomedicines, 2021. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges. Papers, record 34829969. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34829969

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges.
PubMed
Journal
Biomedicines
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.92
iCite
Revised in PubMed
2023-11-08
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kandimalla RRameshhttps://orcid.org/0000-0002-3313-4393
2Chakraborty PPratikhttps://orcid.org/0000-0002-7880-7854
3Vallamkondu JJayalakshmi
4Chaudhary AAnupamahttps://orcid.org/0000-0001-9619-8813
5Samanta SSonalinandini
6Reddy PHP Hemachandrahttps://orcid.org/0000-0002-9560-9948
7De Feo VVincenzohttps://orcid.org/0000-0002-1070-3207
8Dewanjee SSaikathttps://orcid.org/0000-0001-9085-4226

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References216

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132075877Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.Science2020https://conductscience.org/library/papers/32075877PubMed
233923530Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database.Vaccines (Basel)2021https://conductscience.org/library/papers/33923530PubMed
333883164Covid-19: Unusual blood clots are "very rare side effect" of Janssen vaccine, says EMA.BMJ2021https://conductscience.org/library/papers/33883164PubMed
433956782Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.MMWR Morb Mortal Wkly Rep2021https://conductscience.org/library/papers/33956782PubMed
533935343Sputnik V vaccine goes global.New Sci2021https://conductscience.org/library/papers/33935343PubMed
634190859CoronaVac can induce the production of anti-SARS-CoV-2 IgA antibodies in human milk.Clinics (Sao Paulo)2021https://conductscience.org/library/papers/34190859PubMed
732789505Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.JAMA2020https://conductscience.org/library/papers/32789505PubMed
833479399COVID-19 vaccines: where we stand and challenges ahead.Cell Death Differ2021https://conductscience.org/library/papers/33479399PubMed
934358154Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients-A Single-Center Experience.Vaccines (Basel)2021https://conductscience.org/library/papers/34358154PubMed
1033460347SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.Ann Intern Med2021https://conductscience.org/library/papers/33460347PubMed
1134358195Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants.Vaccines (Basel)2021https://conductscience.org/library/papers/34358195PubMed
1232722908Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.N Engl J Med2020https://conductscience.org/library/papers/32722908PubMed
1332231345Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.Cell Res2020https://conductscience.org/library/papers/32231345PubMed
1433306989Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.Lancet2021https://conductscience.org/library/papers/33306989PubMed
1534099338Breakthrough COVID-19 case after full-dose administration of CoronaVac vaccine.Indian J Med Microbiol2021https://conductscience.org/library/papers/34099338PubMed
1632800805COVID-19 Vaccine: A comprehensive status report.Virus Res2020https://conductscience.org/library/papers/32800805PubMed
1734161817Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.J Infect2021https://conductscience.org/library/papers/34161817PubMed
1834206727Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in CoronaVac Vaccinees in Brazil.Viruses2021https://conductscience.org/library/papers/34206727PubMed
1934222133Acute myocarditis associated with anti-COVID-19 vaccination.Clin Exp Vaccine Res2021https://conductscience.org/library/papers/34222133PubMed
2032645974SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings.Pathogens2020https://conductscience.org/library/papers/32645974PubMed

See all 216 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
37784095Investigating the tendency to use COVID-19 vaccine booster dose in Iran.BMC Health Serv Res2023https://conductscience.org/library/papers/37784095PubMed
37376684The Pathogenesis of Cytomegalovirus and Other Viruses Associated with Hearing Loss: Recent Updates.Viruses2023https://conductscience.org/library/papers/37376684PubMed
37261578Pathways to Immunity: Patterns of Excess Death Across the United States and Within Closed Religious Communities.J Relig Health2023https://conductscience.org/library/papers/37261578PubMed
36844687Exploring the experience of developing COVID-19 vaccines in Iran.Clin Exp Vaccine Res2023https://conductscience.org/library/papers/36844687PubMed
36528447Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity.Vaccine2023https://conductscience.org/library/papers/36528447PubMed
36479305Understanding the Attitudes and Willingness of Adult Chinese Patients with Rheumatic Diseases Towards COVID-19 Vaccination.Risk Manag Healthc Policy2022https://conductscience.org/library/papers/36479305PubMed
36430684Molecular Mechanisms of Pathogenesis, Prevention, and Therapy of COVID-19: Summarizing the Results of 2021.Int J Mol Sci2022https://conductscience.org/library/papers/36430684PubMed
36381644COVID-19 and its genomic variants: Molecular pathogenesis and therapeutic interventions.EXCLI J2022https://conductscience.org/library/papers/36381644PubMed
36298563Immunization with a Prefusion SARS-CoV-2 Spike Protein Vaccine (RBMRNA-176) Protects against Viral Challenge in Mice and Nonhuman Primates.Vaccines (Basel)2022https://conductscience.org/library/papers/36298563PubMed
35910658A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19.Front Microbiol2022https://conductscience.org/library/papers/35910658PubMed
35857146Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light.Arch Virol2022https://conductscience.org/library/papers/35857146PubMed
35740269Thrombotic Complications after COVID-19 Vaccination: Diagnosis and Treatment Options.Biomedicines2022https://conductscience.org/library/papers/35740269PubMed
35458489Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena.Viruses2022https://conductscience.org/library/papers/35458489PubMed
35277864SARS-CoV-2 variants and vulnerability at the global level.J Med Virol2022https://conductscience.org/library/papers/35277864PubMed
35267980Healthy Immunity on Preventive Medicine for Combating COVID-19.Nutrients2022https://conductscience.org/library/papers/35267980PubMed
35214652Comparing SARS-CoV-2 Antibody Responses after Various COVID-19 Vaccinations in Healthcare Workers.Vaccines (Basel)2022https://conductscience.org/library/papers/35214652PubMed
35065135Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic.Int J Biol Macromol2022https://conductscience.org/library/papers/35065135PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34829969

GET https://conductscience.org/api/papers/v1/34829969/references?page=2